Medexus Pharmaceuticals Inc. (TSX: MDP)

Canada flag Canada · Delayed Price · Currency is CAD
1.600
-0.020 (-1.23%)
May 17, 2024, 3:59 PM EDT
30.08%
Market Cap 39.13M
Revenue (ttm) 157.59M
Net Income (ttm) 8.01M
Shares Out 24.46M
EPS (ttm) 0.40
PE Ratio 4.10
Forward PE 14.53
Dividend n/a
Ex-Dividend Date n/a
Volume 2,725
Open 1.640
Previous Close 1.620
Day's Range 1.600 - 1.640
52-Week Range 1.120 - 3.530
Beta 1.82
Analysts n/a
Price Target 3.21 (+100.62%)
Earnings Date Jun 19, 2024

About Medexus Pharmaceuticals

Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. The company focuses on the therapeutic areas comprising oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology. Its primary products are IXINITY, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with hemophilia B; Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; Rupall, a prescription allergy m... [Read more]

Sector Healthcare
CEO Kenneth d'Entremont
Country Canada
Stock Exchange Toronto Stock Exchange
Ticker Symbol MDP
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.